Loading video...

Video Failed to Load

Go Home

— A thread for dramas this may premiere in 2026 I'm really anxious and can't wait to see these dramas and learn the story of each of these characters.

26,244 views • 2 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

How strong is Xiao Zhan at carrying dramas across three genres? The three dramas he currently has lined up for release are the clearest answer to why platforms and investors are willing to back him. Today, let’s not look at this from a fan perspective. Let’s talk from an industry point of view and talk about the three upcoming dramas Xiao Zhan currently has: “SpyING” “The Infinite 10 Days” “A Small Town Remedy” A lot of people only see a top star dominating the screen, but what I see is another signal. Genre dramas paired with top-tier actors are reshaping market expectations. First, let’s look at what lanes these three dramas fall into: spy, suspense, and medical. Have you noticed that all three of these genres have a built-in audience base, but at the same time depend heavily on word of mouth? Spy dramas tend to attract slightly older viewers. They require solid logic and strong acting. Suspense dramas mainly target younger audiences. They’re highly plot-driven, with fast pacing and frequent twists. Medical dramas have the widest reach. From students to older viewers, anyone might watch them, because they deal with life and death, human nature, and social issues. One actor, Xiao Zhan, spans all three lanes. That means when his dramas are scheduled, they won’t compete within the same genre. Spy dramas draw from the spy audience. Suspense dramas draw from the suspense audience. Medical dramas draw from the realistic drama audience. Three audiences, three tables, with no overlap or competition. That’s the strategic value of pairing a top-tier actor with genre dramas. You use the actor’s broad public appeal to raise the ceiling of these genres, and then use the quality of the genres to feed back into the actor’s versatility. Next, let’s talk about what it means to “carry a drama.” It’s not about fans inflating the numbers. It means that once a drama airs, it can attract casual viewers, bring a relatively niche genre into the mainstream, and drive new user growth on the platform, while ad deals and overseas distribution also move up a level. Xiao Zhan’s past works have already proven this ability. “The Youth Memories” brought new life to period dramas. “Legend of Zang Hai” gave costume political dramas a different feel. Now platforms are handing him these three key projects. At its core, this is essentially an investment in certainty. In today’s film and TV industry, where everything is generally more cautious, whoever can offer that kind of certainty is the scarcest resource right now. And there’s one detail worth noting: none of these three dramas are what you’d call “safe choices.” Spy dramas haven’t had many big hits in recent years and can easily end up feeling dull. Suspense dramas are fiercely competitive. Hundreds are released every year, but only a few stand out. Medical dramas are where things most often go wrong. If the medical details aren’t accurate, they’ll immediately get criticized online. But it’s exactly these genres that are hard to pull off that need an actor who can make people want to click. Xiao Zhan is that entry point. Audiences are willing to trust him. From a business perspective, the ability of these three dramas to attract sponsors is hardly in doubt. Xiao Zhan’s commercial value has already been proven time and again. Even before airing, his dramas can lock in multiple brand partnerships. And product placement in genre dramas is much more flexible than in costume dramas. Medical dramas can feature healthcare, pharmaceutical, and insurance brands. Spy dramas can include cars, alcohol, and menswear. Suspense dramas can feature tech products and energy drinks. There’s a lot of room for brand placements. Not to mention overseas distribution. Xiao Zhan’s dramas have a stable audience in Southeast Asia, Japan, Korea, and even Europe and the US. “The Untamed” opened the overseas market, and every project since then has consistently sold well overseas. These three different genres actually match different regional preferences. Suspense dramas perform well in Korea. Medical dramas have a market in Japan. Spy dramas have steady demand among overseas Chinese audiences. So I’d say, these three upcoming dramas in Xiao Zhan’s hands are not just something for fans to get excited about, but also a bellwether for the industry. They show that truly capable actors aren’t limited by genre, and that platforms with vision are willing to give the best scripts to actors who can truly deliver. Three dramas, three genres, three possibilities. As a viewer, what I’m most looking forward to is not which one will be a hit, but whether Xiao Zhan can use these three works to make another leap, from a top traffic star to a leading force in genre dramas. As for the answer, we’ll find out when they air. Cr. 刘大可来了 #XiaoZhan #肖战 #TheInfinite10Days #SpyINGtheDrama #ASmallTownRemedy

Xiao Zhan World ♥️ Adoki

14,651 views • 3 months ago